A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)
Clinical trial NCT03724916 · COMPLETED
Trial details
- NCT number
- NCT03724916
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-26
- Primary completion
- 2021-11-04
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.